HUMA: Humacyte, Inc. Stock

by  •  • Comments Off on HUMA: Humacyte, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 240.43
Enterprise Value ($M) 259.75
Book Value ($M) -52.67
Book Value / Share -0.34
Price / Book -4.57
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -5.08
Return on Assets (ROA) -0.92
Return on Equity (ROE) -5.69

Liquidity (mrq)
Quick Ratio 0.00
Current Ratio 2.40

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -114.40
Net Income n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -98.12
Cash from Investing n/a
Cash from Financing 114.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-20 13D/A Niklason Laura E 4.60 -22.03
11-08 13G BlackRock, Inc. 6.30 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 924,484 2,842,935 32.52
2025-04-16 413,359 1,465,632 28.20
2025-04-15 328,138 1,463,474 22.42
2025-04-14 921,164 3,101,932 29.70

(click for more detail)

Similar Companies
HALO – Halozyme Therapeutics, Inc. HLVX – HilleVax, Inc.
HOWL – Werewolf Therapeutics, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc.


Financial data and stock pages provided by
Fintel.io